Morton Brown Family Wealth LLC Buys 281 Shares of The Procter & Gamble Company (NYSE:PG)

Morton Brown Family Wealth LLC increased its stake in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 206.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 417 shares of the company’s stock after acquiring an additional 281 shares during the quarter. Morton Brown Family Wealth LLC’s holdings in Procter & Gamble were worth $61,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. Wyrmwood Management LLC purchased a new position in shares of Procter & Gamble in the 4th quarter valued at approximately $29,000. Mendota Financial Group LLC raised its stake in Procter & Gamble by 636.6% during the fourth quarter. Mendota Financial Group LLC now owns 302 shares of the company’s stock valued at $44,000 after buying an additional 261 shares during the last quarter. Itau Unibanco Holding S.A. bought a new stake in shares of Procter & Gamble in the 2nd quarter worth $50,000. CGC Financial Services LLC bought a new stake in shares of Procter & Gamble in the 2nd quarter worth $55,000. Finally, VitalStone Financial LLC bought a new stake in shares of Procter & Gamble in the 2nd quarter worth $60,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Trading Down 0.3 %

NYSE PG traded down $0.39 during trading hours on Friday, hitting $155.45. 925,475 shares of the company were exchanged, compared to its average volume of 6,794,954. The stock has a 50-day moving average price of $159.38 and a 200 day moving average price of $152.54. The company has a quick ratio of 0.44, a current ratio of 0.64 and a debt-to-equity ratio of 0.48. The Procter & Gamble Company has a 52 week low of $141.45 and a 52 week high of $163.14. The stock has a market cap of $365.78 billion, a PE ratio of 26.04, a price-to-earnings-growth ratio of 3.21 and a beta of 0.44.

Procter & Gamble (NYSE:PGGet Free Report) last released its earnings results on Tuesday, January 23rd. The company reported $1.84 EPS for the quarter, beating analysts’ consensus estimates of $1.70 by $0.14. Procter & Gamble had a return on equity of 34.04% and a net margin of 17.60%. The firm had revenue of $21.44 billion for the quarter, compared to analysts’ expectations of $21.48 billion. During the same quarter in the prior year, the firm posted $1.59 earnings per share. The company’s quarterly revenue was up 3.2% on a year-over-year basis. Analysts forecast that The Procter & Gamble Company will post 6.45 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be issued a dividend of $1.0065 per share. The ex-dividend date is Thursday, April 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.59%. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s dividend payout ratio is currently 62.98%.

Insider Activity

In other news, CEO R. Alexandra Keith sold 776 shares of the stock in a transaction on Monday, March 4th. The stock was sold at an average price of $158.11, for a total transaction of $122,693.36. Following the completion of the sale, the chief executive officer now owns 4,859 shares in the company, valued at approximately $768,256.49. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Procter & Gamble news, CEO R. Alexandra Keith sold 776 shares of Procter & Gamble stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $158.11, for a total transaction of $122,693.36. Following the completion of the transaction, the chief executive officer now owns 4,859 shares in the company, valued at approximately $768,256.49. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Marc S. Pritchard sold 101,704 shares of Procter & Gamble stock in a transaction dated Wednesday, January 24th. The shares were sold at an average price of $153.57, for a total value of $15,618,683.28. Following the transaction, the insider now owns 163,428 shares of the company’s stock, valued at approximately $25,097,637.96. The disclosure for this sale can be found here. In the last quarter, insiders sold 279,063 shares of company stock worth $43,187,745. Insiders own 0.17% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently commented on the company. UBS Group lifted their price objective on Procter & Gamble from $172.00 to $178.00 and gave the stock a “buy” rating in a report on Wednesday, January 24th. Stifel Nicolaus lifted their price objective on Procter & Gamble from $155.00 to $157.00 and gave the stock a “hold” rating in a report on Wednesday, January 24th. Royal Bank of Canada lifted their price objective on Procter & Gamble from $156.00 to $157.00 and gave the stock a “sector perform” rating in a report on Wednesday, January 24th. Deutsche Bank Aktiengesellschaft lifted their price objective on Procter & Gamble from $170.00 to $172.00 and gave the stock a “buy” rating in a report on Wednesday, April 3rd. Finally, Truist Financial raised Procter & Gamble from a “hold” rating to a “buy” rating and boosted their price target for the company from $160.00 to $175.00 in a report on Monday, March 11th. Seven investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average target price of $168.35.

View Our Latest Analysis on Procter & Gamble

About Procter & Gamble

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Further Reading

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.